DS
CDLX icon

David Shaw’s Cardlytics CDLX Stock Holding History

David Shaw’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,710
Closed -$58.1K – 4269
2023
Q1 		$58.1K Sell
1,710
-12,680
-88% -$662K ﹤0.01% 4028
2022
Q4 		$832K Sell
14,390
-3,240
-18% -$200K ﹤0.01% 3561
2022
Q3 		$1.66M Buy
17,630
+13,610
+339% +$1.94M ﹤0.01% 3164
2022
Q2 		$897K Buy
+4,020
New +$1.35M ﹤0.01% 3711
2021
Q2 		– Sell
-550
Closed -$603K – 4766
2021
Q1 		$603K Buy
+550
New +$726K ﹤0.01% 3416

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

David Shaw's CDLX Position: Q1 2026 in Review

David Shaw sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 2,621 shares — an estimated $30.1K sold.

David Shaw first reported a position in CDLX in Q4 2019 and held it in 25 quarters. The position peaked at $25.6M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • David Shaw reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 2,621 Cardlytics shares in Q1 2026, an estimated $30.1K.
  • David Shaw first reported a position in Cardlytics in Q4 2019 and held it in 25 quarters.
  • David Shaw's Cardlytics position peaked at $25.6M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.